Laboratory research record on GLP-1S [PMID: 41054677] PubMed laboratory record discussing GLP-1S in a research context
Now the shift is moving toward something deeper: Energy
The enhancement of Nrf2 transcription with sulforaphane or melatonin could benefit patients with LONG COVID (Post-Acute Sequelae of SARS-CoV-2 or Post-COVID-Syndrome), a significant proportion (approximately 40%) of individuals with COVID-19 experiencing a variety of symptoms (loss of smell and/or taste, fatigue, cough, aching pain, brain fog, insomnia, shortness of breath, and tachycardia) after 12 weeks (Jarrott et al., 2022
Now, this is probably the most complicated slide Im going to show
As such, it may be effective in wiping out SIBO but your gut may not easily or ever recover properly from the impact it has on the microbiome
This protocol, along with a healthy nutrition and exercise regimen will produce the greatest results